NCT05202899: An overdue trial by Guangzhou General Hospital of Guangzhou Military Command
This trial is overdue. It was due to report 1 year, 8 months ago.
Think we've made a mistake? Before contacting us, review the criteria in our paper. In particular, bear in mind the following:
- We can only rely on the structured data that sponsors put into the registry: they may enter incorrect or incomplete data.
- Reporting in a journal is not enough. The FDAAA rules state that the trial must be reported on ClinicalTrials.gov.
- Terminated trials are required to report results. Only withdrawn trials (which never recruited a single patient) are not.
Full data
Full entry on ClinicalTrials.gov | NCT05202899 |
---|---|
Title | Effect of Sugammadex for Reversal of Rocuronium-induced Neuromuscular Block on Perioperative Management of Awake Craniotomy |
Results Status | Overdue |
ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
Start date | Sept. 1, 2020 |
Completion date | Feb. 28, 2022 |
Required reporting date | Feb. 28, 2023, midnight |
Actual reporting date | None |
Date last checked at ClinicalTrials.gov | Feb. 9, 2024 |
Days late | 346 |